Microarrays & Multiplexing
News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is now poised to launch a microarray-based test for urinary tract infections.
Ampel BioSolutions Developing Molecular Test to Predict Kidney Damage in Lupus Nephritis Patients
Premium
The test may also be able to identify patients who are most likely to respond to the 45 different drugs for lupus nephritis that are in clinical trials.
Spectrum Solutions Acquires MDx Lab Alimetrix, Array Maker Microarrays Inc.
Spectrum said that the transactions will help expand its presence in the laboratory testing and custom assay services markets.
The researchers have been developing supramolecular assays based on chemiluminescent chemosensors that can detect metabolites in saliva, blood, and urine.
Immunovia Reducing Headcount, Realigning to Focus on Pancreatic Cancer Test Commercialization
The firm said it will reduce in-house R&D staff from its operations in Lund, Sweden, as it focuses on bringing the ImmRay PanCan-d test to the US market.